Clinical Trial Update: Safety and Efficacy of Clobetasol Propionate 0.05% E Foam in Alopecia [Phase 4]

View source ↗

Summary

This document provides an update on a Phase 4 trial evaluating the safety and efficacy of Clobetasol Propionate 0.05% E Foam for alopecia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alopecia

Drugs mentioned

• Clobetasol Propionate 0.05% E Foam (clobetasol propionate)

Snippet

Sponsor: Callender Center for Clinical Research | Conditions: Alopecia | Phase 4 | Status: UNKNOWN